World’s 1st Total Knee Replacement Patient Treated with PolarisAR Breakthrough Mixed-Reality Surgical Guidance System

STELLAR Knee ushers in a new era of mixed-reality total joint arthroplasty

PolarisAR

PolarisAR, a developer of advanced mixed-reality surgical guidance technology, announced the first total knee arthroplasty (TKA) using its STELLAR Knee mixed-reality surgical guidance system.

The procedure was performed at New York-Presbyterian/Columbia University Irving Medical Center in New York.

STELLAR Knee

STELLAR Knee is a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.

Paul Mikus, CEO of PolarisAR

“STELLAR Knee represents a paradigm shift in the OR, as we aim to offer surgeons robot-like precision and real-time guidance throughout TKA procedures. STELLAR Knee also fills a crucial gap in hospitals where existing robotic systems may already be in use. By seamlessly integrating into surgical workflows and delivering comparable precision in a mixed reality format, STELLAR Knee ensures that every patient can now access the highest standard of care.”

FDA

The U.S. Food & Drug Administration (FDA) cleared the STELLAR Knee mixed-reality surgical guidance system in November 2023 for use in TKA procedures.

The STELLAR Knee system is designed to offer precise control over intraoperative variables compared to traditional instruments, navigation systems, and first-generation augmented reality. Through meticulous measurement, planning and guidance, it enables surgeons to optimize lower limb alignment, soft tissue balance, joint line maintenance and component positioning.

Over the next coming several weeks, STELLAR Knee’s commercial launch will continue at leading institutions throughout the U.S.

Traditional Techniques for TKA

Traditional techniques for TKA have long been associated with various challenges and limitations. Surgeons often face difficulties in achieving precise alignment and balance of the lower limb. Additionally, closed implant systems and preoperative imaging methods may restrict flexibility and customization, limiting the surgeon’s ability to tailor the procedure to individual patient needs. In addition, traditional robotic technologies, with their large intraoperative footprint, can present barriers to widespread adoption. By contrast, Stellar Knee is agnostic to implant and imageless, making it more accessible to surgeons. The democratization of enabling technologies is a key objective for PolarisAR.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.